RAONF Stock: Race Oncology Limited Stock Price, Analysis & Insights
Get live RAONF stock price $2.60, comprehensive Race Oncology Limited stock analysis, charts, news, and expert forecast. Real-time RAONF stock data and investment insights.
Loading chart data...
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Based in Sydney, Australia, Race Oncology Limited is an Australian precision oncology firm that commenced operations in 2011. The company's primary focus is the development of Zantrene, a potent small molecule designed to inhibit the fatso/fat mass a...
Company Information
- CEO
- Daniel Tillett
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- N/A
Contact Information
- Website
- https://www.raceoncology.com
- Address
- Gateway, 1 Macquarie Place
- Country
- AU
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Higher growth potential with elevated volatility (Beta: 1.91)
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Race Oncology Limited shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Race Oncology Limited
- ⚠Investors should consider how Race Oncology Limited fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
451.73M
P/E Ratio (TTM)
-43.33
Beta
1.91
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare RAONF with peer companies:
- Price
- $1.00
- Market cap
- 437.41M
- Price
- $3.29
- Market cap
- 216.40M
- Price
- $6.19
- Market cap
- 312.18M
- Price
- $0.19
- Market cap
- 30.99M
- Price
- $1.80
- Market cap
- 193.79M
- Price
- $34.39
- Market cap
- 1.23B
- Price
- $0.19
- Market cap
- 313.96M
- Price
- $1.86
- Market cap
- 453.24M
- Price
- $6.19
- Market cap
- 567.36M
- Price
- $1.30
- Market cap
- 470.36M
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.